CII
NTUS

CR Intrinsic Investors’s Natus Medical Inc NTUS Stock Holding History

CR Intrinsic Investors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-82,134
Closed -$1.17M – 385
2013
Q3 		$1.17M Buy
+82,134
New +$1.1M 0.04% 313

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CR Intrinsic Investors's NTUS Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Natus Medical Inc (NTUS) in Q4 2013, closing a stake of 82,134 shares — an estimated $1.17M sold.

CR Intrinsic Investors first reported a position in NTUS in Q3 2013 and held it in 1 quarter. The position peaked at $1.17M in Q3 2013. 162 funds tracked by Wall St. Rank hold NTUS as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Natus Medical Inc position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 82,134 Natus Medical Inc shares in Q4 2013, an estimated $1.17M.
  • CR Intrinsic Investors first reported a position in Natus Medical Inc in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Natus Medical Inc position peaked at $1.17M in Q3 2013.
  • 162 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.